Meet Our Team
Legacy BioDesign LLC was started in 2004 by Susan Manning (President) and Mark Manning (Chief Scientific Officer). Legacy provides contract formulation and assay development services to customers all over the world, focusing on biopharmaceuticals.
Legacy was founded on building personal relationships with our clients, as we are truly committed to their success. Our goal is to leave a legacy of quality, integrity, and efficiency. We look forward to the opportunity to work with you on your product development challenges.
 |
Dr. Mark Manning Dr. Manning has been involved in the development of biopharmaceutical products since 1988, when he joined the faculty at the University of Kansas. He then moved to the University of Colorado, where he helped found the Center for Pharmaceutical Biotechnology, what is widely considered to be the leading educational program in the country for training formulation scientists to handle biotechnology-based products. Dr. Manning has consulted for over 40 companies on a wide variety of projects. In addition, he has directed numerous formulation development projects for clients, first as CTO for HTD BioSystems and then as Chief Scientific Officer for Legacy BioDesign. Dr. Manning has published over 100 scientific articles, holds five US patents, and has edited three books on protein formulation. Dr. Manning received an A.B. degree in chemistry from Hope College and his M.S. and Ph.D. degrees from Northwestern University. He conducted post-doctoral work at Colorado State University. |
|
 |
Susan Manning President [email protected] Susan Manning is President of Legacy BioDesign LLC and is responsible for the financial, logistical, and personnel aspects of the operation. She attended Colorado State University and is a successful sole proprietor in her own right. Under her leadership, Legacy BioDesign has exhibited significant growth each year, with clients and partners in nearly a dozen countries around the world. |
|
 |
Dr. Robert W. Payne Principal Scientist [email protected] Dr. Payne is Principal Scientist, overseeing formulation and assay development projects. He received his bachelor's degree in chemistry and biology from the University of Colorado at Denver. After graduation, Robby worked at Nektar for three years on various projects, including Exubera, in the analytical group. Dr. Payne received his Ph.D. from Dr. Charles Henry at Colorado State University on predicting the physical stability of biopolymers. |
|
 |
Dr. Ryan Holcomb Principal Scientist [email protected] Dr. Ryan Holcomb received his B.S. degree in Chemistry (with a Biochemistry focus) from Oregon State University and his Ph.D. in analytical chemistry from Colorado State University. Ryan worked at Bend Research, Inc. and OptiEnz Sensors LLC before joining Legacy as Scientist in 2012. |
|
 |
Dr. Josh Stillahn Senior Scientist [email protected] Dr. Joshua Stillahn joined Legacy in 2016, having completed his undergraduate work at the University of Puget Sound and receiving his Ph.D. in Chemistry from Colorado State University. Josh leverages industry experience along with his background in analytical and physical chemistry as he works to advance Legacy’s efforts in pharmaceutical formulations. |
|
|
Gabe Evans Project Manager [email protected] Gabe Evans is Project Manager at Legacy BioDesign. He conducted work at the University of Colorado Health Sciences Center prior to joining Legacy. Gabe holds a B.S. degree from Southwest Baptist University. He performs SIC and capillary electrophoresis analyses, in addition to his other duties. |
|
 |
Michael Mann joined Legacy BioDesign in September 2009 as the Web Site Administrator. Michael holds an associates degree from Grand Rapids Community College. He worked for more than twelve years as a transportation dispatcher as well as a billing and payroll clerk. Most recently, Michael served as the web administrator for his church in Grand Rapids, MI. |
